BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20833054)

  • 1. Diversity-oriented synthesis of cyclic acyldepsipeptides leads to the discovery of a potent antibacterial agent.
    Socha AM; Tan NY; LaPlante KL; Sello JK
    Bioorg Med Chem; 2010 Oct; 18(20):7193-202. PubMed ID: 20833054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restriction of the conformational dynamics of the cyclic acyldepsipeptide antibiotics improves their antibacterial activity.
    Carney DW; Schmitz KR; Truong JV; Sauer RT; Sello JK
    J Am Chem Soc; 2014 Feb; 136(5):1922-9. PubMed ID: 24422534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ADEP Biosynthetic Gene Cluster in Streptomyces hawaiiensis NRRL 15010 Reveals an Accessory
    Thomy D; Culp E; Adamek M; Cheng EY; Ziemert N; Wright GD; Sass P; Brötz-Oesterhelt H
    Appl Environ Microbiol; 2019 Oct; 85(20):. PubMed ID: 31399403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and antibacterial activity of demethylvancomycin analogues against drug-resistant bacteria.
    Chang J; Zhang SJ; Jiang YW; Xu L; Yu JM; Zhou WJ; Sun X
    ChemMedChem; 2013 Jun; 8(6):976-84. PubMed ID: 23576378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
    Sader HS; Watters AA; Fritsche TR; Jones RN
    BMC Infect Dis; 2007 Apr; 7():29. PubMed ID: 17442104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
    Chen YH; Liu CY; Lu JJ; King CH; Hsueh PR
    J Antimicrob Chemother; 2009 Dec; 64(6):1226-9. PubMed ID: 19833635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell Division Protein FtsZ Is Unfolded for N-Terminal Degradation by Antibiotic-Activated ClpP.
    Silber N; Pan S; Schäkermann S; Mayer C; Brötz-Oesterhelt H; Sass P
    mBio; 2020 Jun; 11(3):. PubMed ID: 32605984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bottromycin derivatives: efficient chemical modifications of the ester moiety and evaluation of anti-MRSA and anti-VRE activities.
    Kobayashi Y; Ichioka M; Hirose T; Nagai K; Matsumoto A; Matsui H; Hanaki H; Masuma R; Takahashi Y; Omura S; Sunazuka T
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6116-20. PubMed ID: 20833545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antibacterial activity of novel 4''-carbamates of 6,11-di-O-methylerythromycin A.
    Wu Z; Lu Y; Luo M; He X; Xiao Y; Yang J; Pan Y; Qiu G; Xu Y; Huang W; Long P; Li R; Hu X
    J Antibiot (Tokyo); 2010 Jul; 63(7):343-50. PubMed ID: 20448668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antibacterial studies of binaphthyl-based tripeptoids. Part 1.
    Bremner JB; Keller PA; Pyne SG; Boyle TP; Brkic Z; David DM; Robertson M; Somphol K; Baylis D; Coates JA; Deadman J; Jeevarajah D; Rhodes DI
    Bioorg Med Chem; 2010 Apr; 18(7):2611-20. PubMed ID: 20236828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multivalent approach to drug discovery for novel antibiotics.
    Long DD; Aggen JB; Christensen BG; Judice JK; Hegde SS; Kaniga K; Krause KM; Linsell MS; Moran EJ; Pace JL
    J Antibiot (Tokyo); 2008 Oct; 61(10):595-602. PubMed ID: 19168973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Characterization of Potent Cyclic Acyldepsipeptide Analogues with Increased Antimicrobial Activity.
    Goodreid JD; Janetzko J; Santa Maria JP; Wong KS; Leung E; Eger BT; Bryson S; Pai EF; Gray-Owen SD; Walker S; Houry WA; Batey RA
    J Med Chem; 2016 Jan; 59(2):624-46. PubMed ID: 26818454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationship of dicationic diaryl ethers as novel potent anti-MRSA and anti-VRE agents.
    Hu L; Kully ML; Boykin DW; Abood N
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4626-9. PubMed ID: 19589676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure determination and total synthesis of bottromycin A2: a potent antibiotic against MRSA and VRE.
    Shimamura H; Gouda H; Nagai K; Hirose T; Ichioka M; Furuya Y; Kobayashi Y; Hirono S; Sunazuka T; Omura S
    Angew Chem Int Ed Engl; 2009; 48(5):914-7. PubMed ID: 19115340
    [No Abstract]   [Full Text] [Related]  

  • 15. Design, synthesis, and biological evaluation of a novel series of quercetin diacylglucosides as potent anti-MRSA and anti-VRE agents.
    Hossion AM; Otsuka N; Kandahary RK; Tsuchiya T; Ogawa W; Iwado A; Zamami Y; Sasaki K
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5349-52. PubMed ID: 20655215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of bacterial proteolytic machinery by a new class of antibiotics.
    Brötz-Oesterhelt H; Beyer D; Kroll HP; Endermann R; Ladel C; Schroeder W; Hinzen B; Raddatz S; Paulsen H; Henninger K; Bandow JE; Sahl HG; Labischinski H
    Nat Med; 2005 Oct; 11(10):1082-7. PubMed ID: 16200071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of benzenesulfonanilides active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
    Namba K; Zheng X; Motoshima K; Kobayashi H; Tai A; Takahashi E; Sasaki K; Okamoto K; Kakuta H
    Bioorg Med Chem; 2008 Jun; 16(11):6131-44. PubMed ID: 18468909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
    Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
    J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and antibacterial activity of 3-methylenepyrrolidine formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
    Shi W; Ma H; Duan Y; Aubart K; Fang Y; Zonis R; Yang L; Hu W
    Bioorg Med Chem Lett; 2011 Feb; 21(3):1060-3. PubMed ID: 21185180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel semisynthetic derivative of antibiotic Eremomycin active against drug-resistant gram-positive pathogens including Bacillus anthracis.
    Maples KR; Wheeler C; Ip E; Plattner JJ; Chu D; Zhang YK; Preobrazhenskaya MN; Printsevskaya SS; Solovieva SE; Olsufyeva EN; Heine H; Lovchik J; Lyons CR
    J Med Chem; 2007 Jul; 50(15):3681-5. PubMed ID: 17608397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.